Get started
Author

Chalita Lagampan

Observed name: C. Lagampan
Institution: Chonburi Hospital
ORCID: 0000-0001-6103-3373
Observed ORCID: 0000-0001-6103-3373
OpenAlex ID: A5006278386
Lactic acidosis, a potential toxicity from drug–drug interaction related to concomitant ribociclib and metformin in preexisting renal insufficiency: A case report
2021 · Chalita Lagampan, Nattaya Poovorawan, et al. · Cancer Reports · 11
An open-label, randomized, controlled trial to evaluate the efficacy of antihistamine premedication and infusion prolongation in prevention of hypersensitivity reaction to oxaliplatin.
2022 · Chalita Lagampan, Nattaya Teeyapan, et al. · Journal of Clinical Oncology · 1
Clinical Treatment Outcomes of Erlotinib in Metastatic Non-Small Cell Lung Cancer Harboring Uncommon EGFR Mutations: A Real-World Data Study
2026 · Chalita Lagampan · Journal of the Medical Association of Thailand
PDF
Comparison of Initial Absolute Monocyte Counts in 7-Day Recovery vs Nonrecovery Neutrophil Counts After Chemotherapy in Patients With Solid Organ Malignancy
2026 · Jittranoot Leelasawat, Chalita Lagampan · Research Medical Journal
PDF
EP.12.22 Clinical Treatment Outcomes of Erlotinib in Metastatic Non-Small Cell Cancer Harboring Uncommon EGFR Mutations
2025 · C. Lagampan · Journal of Thoracic Oncology
MO13-2 Predicting the treatment related toxicity by Geriatric-8 geriatric assessment screening tool
2022 · Annop Kittiwarawut, Kohji Takemura, et al. · Annals of Oncology
The Evaluation of Joint Detection of CA19-9, AFP and CEA in Identification and Diagnosis of Cholangiocarcinoma
2020 · Annop Kittiwarawut, Chalita Lagampan
Works count: 7
Citation count: 12
H-index: 1
I10-index: 1
Year
Topic
Type